azd4877 Pages on BioPortfolio:

BioPortfolio - azd4877
A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer, ... Sloan-Kettering - A Phase I Study of AZD4877 in Patients with . ...
http://www.bioportfolio.com/search/azd4877.html...

BioPortfolio - Urethral Neoplasms
Abdominal Neoplasms - B0006S9SF4 - Richard Bright A Phase II Study of AZD4877 (a ... Bladder Cancer; Transitional Cell Bladder Cancer; Urethra Cancer; . ...
http://www.bioportfolio.com/search/Urethral_Neoplasms.html...

BioPortfolio - Ureteral Cancer Bladder Cancer
BioPortfolio - azd4877 BioPortfolio - Ureteral Cancer Bladder Cancer A Phase II Study of AZD4877 (a ... http://www.bioportfolio.com/search/azd4877.html. ...
http://www.bioportfolio.com/search/Ureteral_Cancer_Bladder_C...

Bladder Neoplasms - 3540608850 - Mark P Schoenberg
Abdominal Neoplasms - B0006S9SF4 - Richard Bright A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer . ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...

BioPortfolio - Ureteral Cancer
A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer, Bladder Cancer; Transitional Cell Bladder Cancer; Urethra Cancer; ...
http://www.bioportfolio.com/indepth/Ureteral_Cancer.html...

Search - B000OKV3VQ - Richard G. Heimberg, Harlan A. Juster ...
BioPortfolio - azd4877 ... http://www.bioportfolio. com/bookshop/Operation/ItemSearch/Se... Search - B0007HJXAO - Robert D Barnes ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...

Bladder Cancer - B0007JSH18 - Knud Lockwood
A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer ... http://www.bioportfolio.com/indepth/Ureteral_Cancer.html. ...
http://www.bioportfolio.com/bookshop/SearchIndex/Books/Opera...

Anti-Angiogenic Cancer Therapy - 0849327997 -
BioPortfolio - azd4877 AMG655. roy Herbst, M.D., Ph.D. Activating peptide against death receptor (DR5) ... http://www.bioportfolio.com/search/azd4877.html. ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...

Results from other life science and pharmaceutical sites:

Sloan-Kettering - A Phase I Study of AZD4877 in Patients with ...
A Phase I Study of AZD4877 in Patients with Advanced Solid Tumors - Schwartz, Gary, MD [Protocol 07-052]
http://www.mskcc.org/mskcc/html/2270.cfm?IRBNO=07-052...

AstraZeneca Business Review 2006 Presentation
AZD4877. AZD7762. AZD3646. AZD7512. AZD2281. (KU59436). AZD3480. CytoFab™. AGI- 1067. Nexium™. Atacand. Plus™. Seroquel™ SR. Seroquel™ SR. AZD9335 ...
http://www.astrazeneca.com/sites/7/imagebank/typearticlepara...

US Oncology - News Articles
30 May 2008 ... tolerability, and pharmacokinetics of AZD4877 administered twice weekly in adult patients with advanced solid malignancies ...
http://www.usoncology.com/CompanyInfo/article.asp?aid=3425...

AstraZeneca First Quarter Results and MedImmune acquisition ...
23 Apr 2007 ... AZD4877. AZD7762. AZD3646. AZD9935. AZD1283. AZD3043. AZD5861. AZD5329. Crestor/ AB. T-335. AZD1656. AZD3988. AZD2066. AZD2066. AZD6280 ...
http://www.astrazeneca.com/sites/7/imagebank/typeArticlepara...

Phase I Clinical Trials Phase I Clinical Trials
AZD4877. roy Herbst, M.D., Ph.D. Cell cycle inhibitor. Advanced cancers. AMG655. roy Herbst, M.D., Ph.D. Activating peptide against death receptor (DR5) ...
http://www.mdanderson.org/pdf/phase1_fallwinter07.pdf...

AstraZeneca Fourth Quarter and Full Year Results 2006 Presentation
AZD4877. AZD7762. AZD3646. AZD9935. Nexium™. AZD8593. Faslodex™. Faslodex™. AZD9272 .... AZD4818. AZD4877. AZD9335. AZD1092. No change. Progression. Merrem™
...
http://www.astrazeneca.com/sites/7/imagebank/typearticlepara...

Sloan-Kettering - Find a Clinical Trial
A Phase I Study of AZD4877 in Patients with Advanced Solid Tumors. [Protocol 07- 052]. Schwartz, Gary, MD. A Phase I Study of AZD7762 plus Irinotecan in ...
http://www.mskcc.org/mskcc/html/2270.cfm...

Microsoft PowerPoint - q4-2007-slides-UPDATED-01FEB.ppt
31 Jan 2008 ... AZD4877. AZD5904. AZD5904. AZD6140. AZD6244. (ARRY-142886). AZD7762 ... AZD4877. AZD5904. AZD5904. AZD1305. AZD7762. AZD8931. CAT-354 ...
http://www.astrazeneca.com/sites/7/imagebank/typeArticlepara...

Cancer Therapy & Research Center at The University of Texas Health ...
ANG1005 · AS1411 · AVE0005 · AVE9633 · AZD4877 · Bevacizumab+ Sorafenib · Bladder · BSI-201 · BSI-201+different chemotherapeutic regimens · C80405 ...
http://www.ctrc.net/research/clinicalname.cfm...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.